Muscle News and Research

RSS

Northwestern Medicine researchers evaluate unique surgical method to treat chronic amputee pain

Northwestern Medicine® researchers are leading a new multi-center clinical trial to evaluate a unique surgical method, known as targeted muscle reinnervation (TMR), to treat chronic pain that can result from limb amputation. Around a quarter of all amputees develop chronic pain in the remaining portion of their amputated limb, which can include phantom limb syndrome (pain that is perceived in the portion of the limb that is gone), and prevents many patients from using prostheses.

5 Feb 2015

Biodegradable microstructures may help repair tissue, prevent heart failure

The delivery of tiny biodegradable microstructures to heart tissue damaged by heart attack may help repair the tissue and prevent future heart failure. A team led by cardiovascular researchers at the Medical College of Wisconsin bioengineered the microstructures to be the same size, shape and stiffness as adult heart muscle cells, or cardiomyocytes, with the goal of releasing biologically active peptides that act as cardioprotective agents.

5 Feb 2015

Scripps Green Hospital treats peripheral artery disease patient using new drug-coated balloon

A doctor at Scripps Green Hospital this week became the first in California to use a new drug-coated balloon to treat peripheral artery disease in a patient since regulatory approval of the IN.PACT Admiral device in January by the Food and Drug Administration.

5 Feb 2015

News study finds association between chronic fatigue syndrome and early menopause

A newfound link between chronic fatigue syndrome (CFS) and early menopause was reported online today in Menopause, the journal of The North American Menopause Society.

4 Feb 2015

Study demonstrates therapeutic potential of new class of synthetic oligonucleotides for DMD treatment

Research efforts associating scientists from the CNRS, UVSQ and INSERM within the Laboratoire END-ICAP, working in collaboration with a team from the University of Bern, has demonstrated the therapeutic potential of a new class of synthetic oligonucleotides in the treatment of Duchenne muscular dystrophy (DMD) using RNA "surgery".

4 Feb 2015

'Mission: Lifeline' initiative aims to improve outcomes for heart attack patients in rural Iowa

The American Heart Association, Midwest Affiliate, announced at a press conference on Tuesday, February 3, 1:00 p.m. in the State Historical Building of the Capitol Complex in Des Moines a $4.6 million grant award to enhance systems of care, save lives, and improve outcomes for heart attack patients in rural Iowa, called Mission: Lifeline.

4 Feb 2015

PPDC awards grants to three companies developing new medical devices for children

The Philadelphia Pediatric Medical Device Consortium announces its first three awards to companies developing new medical devices for children.

4 Feb 2015

Bern researchers develop active substance for treating Duchenne muscular dystrophy

Duchenne muscular dystrophy is a congenital disease which causes muscle degeneration and eventual death in teenagers. Recently, researchers from Bern developed an active substance, which they together with an international team tested successfully.

3 Feb 2015

Janssen granted Priority Review from FDA for YONDELIS (trabectedin) NDA to treat STS patients

Janssen Research & Development, LLC announced today that the U.S. Food and Drug Administration has granted Priority Review for the New Drug Application (NDA) for YONDELIS (trabectedin) to treat patients with advanced soft tissue sarcoma (STS), including liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline.

3 Feb 2015

Not all ARB drugs are equally effective at treating heart failure, reveals NSU researcher

Millions of people take angiotensin receptor blockers (ARBs) to help treat heart failure. But it turns out not all ARBs are created equally, according to one Nova Southeastern University researcher's findings.

3 Feb 2015

UCLA offers new hope to patients suffering from phrenic nerve damage

David Powell could not catch his breath. The 35-year-old from San Diego got winded walking up the stairs, exercising or even just bending over to tie his shoes.

2 Feb 2015

Researchers outline new approach to facelift surgery in patients with massive weight loss

Patients undergoing bariatric surgery for severe obesity are often left with excess, sagging skin affecting all areas of the body--including the face.

2 Feb 2015

Exploring better treatment for adolescent idiopathic scoliosis

Adolescent idiopathic scoliosis (AIS) affects 2-3% of children aged between 10 and 16. It is more common in girls than in boys (with a ratio of 10-1). Besides the obvious physical signs derived from the visible spinal deformity, AIS can cause psychological and emotional problems (low self-esteem, poor self-image body, etc.) that significantly reduces patients' quality of life.

31 Jan 2015

Scientists reveal mechanism underlying cellular degeneration of upper motor neurons

For the first time, scientists have revealed a mechanism underlying the cellular degeneration of upper motor neurons, a small group of neurons in the brain recently shown to play a major role in ALS pathology.

31 Jan 2015

Rare respiratory virus could be linked to severe neurological illness in children

A cluster of children from Colorado in the USA have been treated for muscle weakness or paralysis that may be connected to a nationwide outbreak of a usually rare respiratory virus called enterovirus D68 (EV-D68), one of more than 100 non-polio enteroviruses.

31 Jan 2015

Adropin hormone offers a promising treatment option for type 2 diabetes

In a study published in Molecular Metabolism, a SLU researcher has found that adropin, a hormone that regulates whether the body burns fat or sugar during feeding and fasting cycles, can improve insulin action in obese, diabetic mice, suggesting that it may work as a therapy for type 2 diabetes.

30 Jan 2015

FDA clears AliveCor's automated detectors that record and display ECG rhythm

AliveCor, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted the company clearance for two new algorithms giving users instant feedback on their electrocardiogram (ECG) recordings and expanding its automated interpretation service offerings.

From AliveCor, Inc. 29 Jan 2015

Magnus Life Science commemorates unique partnership with UCL to advance bio-medical research

Magnus Life Science is today celebrating its unique collaboration with University College London (UCL), one of the world's leading universities, to advance bio-medical research and bring real innovation to areas of high unmet medical need.

29 Jan 2015

Investigators make medical breakthrough in repairing tracheal damage

Investigators at The Feinstein Institute for Medical Research have made a medical breakthrough using 3D printing on a MakerBot Replicator 2X Experimental 3D Printer to create cartilage designed for tracheal repair or replacement.

28 Jan 2015

Bronchial thermoplasty for severe asthma: an interview with Dr. Rob Niven

Internationally, severe asthma is defined as anybody who is on maximum therapy, which has no measurable side effects, but still have symptoms of persistent asthma. In the UK, that effectively means people who require oral steroids for their asthma two or more times a year.

27 Jan 2015

Muscle News and Research

Northwestern Medicine researchers evaluate unique surgical method to treat chronic amputee pain

Biodegradable microstructures may help repair tissue, prevent heart failure

Scripps Green Hospital treats peripheral artery disease patient using new drug-coated balloon

News study finds association between chronic fatigue syndrome and early menopause

Study demonstrates therapeutic potential of new class of synthetic oligonucleotides for DMD treatment

'Mission: Lifeline' initiative aims to improve outcomes for heart attack patients in rural Iowa

PPDC awards grants to three companies developing new medical devices for children

Bern researchers develop active substance for treating Duchenne muscular dystrophy

Janssen granted Priority Review from FDA for YONDELIS (trabectedin) NDA to treat STS patients

Not all ARB drugs are equally effective at treating heart failure, reveals NSU researcher

UCLA offers new hope to patients suffering from phrenic nerve damage

Researchers outline new approach to facelift surgery in patients with massive weight loss

Exploring better treatment for adolescent idiopathic scoliosis

Scientists reveal mechanism underlying cellular degeneration of upper motor neurons

Rare respiratory virus could be linked to severe neurological illness in children

Adropin hormone offers a promising treatment option for type 2 diabetes

FDA clears AliveCor's automated detectors that record and display ECG rhythm

Magnus Life Science commemorates unique partnership with UCL to advance bio-medical research

Investigators make medical breakthrough in repairing tracheal damage

Bronchial thermoplasty for severe asthma: an interview with Dr. Rob Niven

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News